|Articles|February 11, 2022
- Applied Clinical Trials-02-01-2022
- Volume 31
- Issue 1/2
Applied Clinical Trials January/February 2022 Issue (PDF)
Advertisement
Articles in this issue
over 4 years ago
Tech Integration for Clinical Trialsover 4 years ago
Integrating Technology and Expertiseover 4 years ago
Salary Survey: The Age of COVIDover 4 years ago
A(nother) New Start for Trial Regulations in Europe?over 4 years ago
A Lesson Learned in Patient Centricityover 4 years ago
In Memoriam: Michael J. Hennessy, Sr. (1960-2021)over 4 years ago
Concerns Mount Over Limited Evidence for Accelerated Approvalsover 4 years ago
Asian Biotech Clinical Trial Demand Moves to the Westover 4 years ago
Creating Future-Ready Teams for Digital Clinical TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
3
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
4
ACT Brief: DIA Leadership and Infrastructure Priorities, Real-Time Data Review Readiness, and CLL Treatment Expansion
5